Scott Hauenstein

Antibody Response to Infliximab and its Impact on Pharmacokinetics can be Transient

Niels Vande Casteele, Ann Gils, Sharat Singh et al. · The American Journal of Gastroenterology · 2013 · 342 citations

The relationship between infliximab concentrations, antibodies to infliximab and disease activity in Crohn's disease

Niels Vande Casteele, Reena Khanna, Barrett G. Levesque et al. · Gut · 2014 · 283 citations · Full text

Development and validation of a homogeneous mobility shift assay for the measurement of infliximab and antibodies-to-infliximab levels in patient serum

Shui-Long Wang, Linda Ohrmund, Scott Hauenstein et al. · Journal of Immunological Methods · 2012 · 203 citations · Full text

Concentrations of 6-Thioguanine Nucleotide Correlate With Trough Levels of Infliximab in Patients With Inflammatory Bowel Disease on Combination Therapy

Andrés Yarur, Maddie Kubiliun, Frank Czul et al. · Clinical Gastroenterology and Hepatology · 2015 · 157 citations · Full text

Inflammation, Trough Levels, Anti-inflammatory +8

Early Trough Levels and Antibodies to Infliximab Predict Safety and Success of Reinitiation of Infliximab Therapy

Filip Baert, David Drobne, Ann Gils et al. · Clinical Gastroenterology and Hepatology · 2014 · 134 citations · Full text

Trough Levels, Autoimmune Disease, Allergy +9